Advanced technologies and consultative services greatly enhance patient management and care. MPLN offers a comprehensive and integrative complement of services:
MPLN’s integrated report follows the completion of all testing on bone marrow samples.
Our in-house multidisciplinary approach utilizes evidence-based medicine to maximize diagnostic information and provide a complete diagnostic picture without performing unnecessary tests.
Coordinating laboratory tests and results within one facility, MPLN provides a single source for anatomic pathology, FISH, flow cytometry, cytogenetics, and molecular testing. Using one source for your laboratory testing provides simpler ordering, downstream testing, reporting, billing, and patient management logistics.
Beyond informing drug target discovery, validation, and clinical development, it uncovers critical genetic markers that drive disease progression and influence individual treatment responses. This empowers healthcare professionals to create more precise, tailored treatment plans, optimizing medical management based on each patient’s genetic profile.
DNA Solutions – WGS*, WGMS*, WES*, TSO-500 Comp, Pillar OncoReveal
RNA Solutions – Total RNA-Seq*, RNA exome*, mRNA*
Liquid Biopsy Solutions – TSO-500 ctDNA, PGDx elio™ plasma complete*
*Offered through fully accredited partner laboratories.
Our advanced technology enables simultaneous visualization of single or multiple biomarkers within the same tissue section, delivering comprehensive insights and precise diagnostics. With unmatched expertise and cutting-edge technology, our team supports you in understanding complex tissue microenvironments, aiding patient stratification and treatment response prediction.